Merck & Co. against Novartis AG — live side-by-side technical comparison.
Prices as of 2026-11-11T15:47:37+00:00 UTC · updates daily
MRK leads 5 of the 7 windows we measure — over 1 month MRK is +0.1% and NVS +10.8%; over year to date MRK is +38.4% and NVS +15.6%. The MRK/NVS price ratio stands at 0.9138, below its 50-day average of 0.9836, and above the 200-day average of 0.843. A ratio above its own average means MRK is gaining on NVS; on this reading the recent edge belongs to NVS.
Compare MRK and NVS: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| MRK | NVS | |
|---|---|---|
| Price | $145.60 | $159.33 |
| 1 day | -1.7%lead | -2.4% |
| 5 days | -3.1%lead | -3.4% |
| 1 month | +0.1% | +10.8%lead |
| 6 months | +30.9%lead | +9.7% |
| Year to date | +38.4%lead | +15.6% |
| 1 year | +60.1%lead | +22.1% |
| 2 years | +44.5% | +50.8%lead |
| 52-week position | 83% of range | 76% of range |
| 52-week range | $90.90–$156.92 | $123.24–$170.46 |
| vs 50-day average | below $146.29 | above $149.21 |
| vs 200-day average | above $128.24 | above $152.44 |
| RSI (14) | 49 | 56 |
| Market cap | $365.0B | — |
| Analyst target | $161.53 (+9.1%) | — |
| Analysts | 26 | — |
| Consensus | Buy | — |
| Next earnings | Oct 29, 2026 | Oct 27, 2026 |
MRK trades at $145.60, below its 50-day average of $146.29, and above the 200-day at $128.24. It sits at 83% of its 52-week range ($90.90–$156.92); 14-day RSI is 49, in neutral territory; an average session moves it about 3.1%. For levels, the first level overhead is $146.29 (0.5% away) and the first support below is $139.01 (4.5% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is bullish.
NVS trades at $159.33, above its 50-day average of $149.21, and above the 200-day at $152.44. It sits at 76% of its 52-week range ($123.24–$170.46); 14-day RSI is 56, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $160.57 (0.8% away) and the first support below is $156.17 (2.0% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
MRK is the more volatile of the two — an average session moves it 3.1% against 2.4% for NVS, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: MRK clearing $146.29 or losing $139.01; NVS clearing $160.57 or losing $156.17. Until one of them gives way, the relative reading above stands.